http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Mon, 15 Jun 2026 06:08:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Haleon+plc++++++++++++++++For%3A+Jun+15/26643709.html si-local-file:///var/storage/secattach/20260615/26643709.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Haleon+plc++++++++++++++++For%3A+Jun+15/26643709.html Mon, 15 Jun 2026 06:08:00 -0400 HLN HLN O.52678883 http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Haleon+plc++++++++++++++++For%3A+Jun+15/26643709.html si-local-file:///var/storage/secattach/20260615/26643709.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Haleon+plc++++++++++++++++For%3A+Jun+15/26643709.html Mon, 15 Jun 2026 06:08:00 -0400 HLN HLN O.52678883 http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Haleon+plc++++++++++++++++For%3A+Jun+15/26643709.html si-local-file:///var/storage/secattach/20260615/26643709.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Haleon+plc++++++++++++++++For%3A+Jun+15/26643709.html Mon, 15 Jun 2026 06:08:00 -0400 HLN HLN O.52678883 http://www.streetinsider.com/Intl+Ratings/Haleon+PLC+%28HLN%3ALN%29+%28HLN%29+PT+Lowered+to+GBP4.30+at+Morgan+Stanley/26643369.html Morgan Stanley analyst Rashad Kawan lowered the price target on Haleon PLC (HLN:LN) (NYSE: HLN) to GBP4.30 (from GBP4.40) while maintaining a Overweight rating. http://www.streetinsider.com/Intl+Ratings/Haleon+PLC+%28HLN%3ALN%29+%28HLN%29+PT+Lowered+to+GBP4.30+at+Morgan+Stanley/26643369.html Mon, 15 Jun 2026 05:18:59 -0400 HLN http://www.streetinsider.com/Intl+Ratings/Haleon+PLC+%28HLN%3ALN%29+%28HLN%29+PT+Lowered+to+GBP4.30+at+Morgan+Stanley/26643369.html Morgan Stanley analyst Rashad Kawan lowered the price target on Haleon PLC (HLN:LN) (NYSE: HLN) to GBP4.30 (from GBP4.40) while maintaining a Overweight rating. http://www.streetinsider.com/Intl+Ratings/Haleon+PLC+%28HLN%3ALN%29+%28HLN%29+PT+Lowered+to+GBP4.30+at+Morgan+Stanley/26643369.html Mon, 15 Jun 2026 05:18:59 -0400 HLN http://www.streetinsider.com/Analyst+PT+Change/Haleon+PLC+%28HLN%3ALN%29+%28HLN%29+PT+Lowered+to+GBP4.30+at+Morgan+Stanley/26643369.html Morgan Stanley analyst Rashad Kawan lowered the price target on Haleon PLC (HLN:LN) (NYSE: HLN) to GBP4.30 (from GBP4.40) while maintaining a Overweight rating. http://www.streetinsider.com/Analyst+PT+Change/Haleon+PLC+%28HLN%3ALN%29+%28HLN%29+PT+Lowered+to+GBP4.30+at+Morgan+Stanley/26643369.html Mon, 15 Jun 2026 05:18:59 -0400 HLN http://www.streetinsider.com/Analyst+PT+Change/Haleon+PLC+%28HLN%3ALN%29+%28HLN%29+PT+Lowered+to+GBP4.30+at+Morgan+Stanley/26643369.html Morgan Stanley analyst Rashad Kawan lowered the price target on Haleon PLC (HLN:LN) (NYSE: HLN) to GBP4.30 (from GBP4.40) while maintaining a Overweight rating. http://www.streetinsider.com/Analyst+PT+Change/Haleon+PLC+%28HLN%3ALN%29+%28HLN%29+PT+Lowered+to+GBP4.30+at+Morgan+Stanley/26643369.html Mon, 15 Jun 2026 05:18:59 -0400 HLN http://www.streetinsider.com/Hot+List/Barclays+identifies+European+consumer+health+winners+and+laggards+as+industry+evolves/26642874.html <p>In recent years, Consumer Health has emerged as a defined category, though it is still a nascent segment within FMCG. A recent Barclays note says the industry could grow to have an estimated market size of $547 billion by 2030E. In the note, firm analysts say the sector is somewhat misunderstood, and identify winners and laggards among European consumer health companies.</p><p>Unilever (LON: ULVR) (NYSE: UL), Haleon (NYSE: HLN) (LON: HLN) and Danone (EPA: BN) (OTC: DANOY) are Barclays’ preferred names in the European Consumer Health space. Barclays’ least preferred names in the space are Beiersdorf (ETR: BEI) (OTC: BDRFY), and http://www.streetinsider.com/Hot+List/Barclays+identifies+European+consumer+health+winners+and+laggards+as+industry+evolves/26642874.html Sun, 14 Jun 2026 04:00:00 -0400 BDRFY DANOY HLN KMB UL http://www.streetinsider.com/Hot+List/Barclays+identifies+European+consumer+health+winners+and+laggards+as+industry+evolves/26642874.html <p>In recent years, Consumer Health has emerged as a defined category, though it is still a nascent segment within FMCG. A recent Barclays note says the industry could grow to have an estimated market size of $547 billion by 2030E. In the note, firm analysts say the sector is somewhat misunderstood, and identify winners and laggards among European consumer health companies.</p><p>Unilever (LON: ULVR) (NYSE: UL), Haleon (NYSE: HLN) (LON: HLN) and Danone (EPA: BN) (OTC: DANOY) are Barclays’ preferred names in the European Consumer Health space. Barclays’ least preferred names in the space are Beiersdorf (ETR: BEI) (OTC: BDRFY), and http://www.streetinsider.com/Hot+List/Barclays+identifies+European+consumer+health+winners+and+laggards+as+industry+evolves/26642874.html Sun, 14 Jun 2026 04:00:00 -0400 BDRFY DANOY HLN KMB UL http://www.streetinsider.com/Hot+List/Barclays+identifies+European+consumer+health+winners+and+laggards+as+industry+evolves/26642874.html <p>In recent years, Consumer Health has emerged as a defined category, though it is still a nascent segment within FMCG. A recent Barclays note says the industry could grow to have an estimated market size of $547 billion by 2030E. In the note, firm analysts say the sector is somewhat misunderstood, and identify winners and laggards among European consumer health companies.</p><p>Unilever (LON: ULVR) (NYSE: UL), Haleon (NYSE: HLN) (LON: HLN) and Danone (EPA: BN) (OTC: DANOY) are Barclays’ preferred names in the European Consumer Health space. Barclays’ least preferred names in the space are Beiersdorf (ETR: BEI) (OTC: BDRFY), and http://www.streetinsider.com/Hot+List/Barclays+identifies+European+consumer+health+winners+and+laggards+as+industry+evolves/26642874.html Sun, 14 Jun 2026 04:00:00 -0400 BDRFY DANOY HLN KMB UL http://www.streetinsider.com/Hot+List/Barclays+identifies+European+consumer+health+winners+and+laggards+as+industry+evolves/26642874.html <p>In recent years, Consumer Health has emerged as a defined category, though it is still a nascent segment within FMCG. A recent Barclays note says the industry could grow to have an estimated market size of $547 billion by 2030E. In the note, firm analysts say the sector is somewhat misunderstood, and identify winners and laggards among European consumer health companies.</p><p>Unilever (LON: ULVR) (NYSE: UL), Haleon (NYSE: HLN) (LON: HLN) and Danone (EPA: BN) (OTC: DANOY) are Barclays’ preferred names in the European Consumer Health space. Barclays’ least preferred names in the space are Beiersdorf (ETR: BEI) (OTC: BDRFY), and http://www.streetinsider.com/Hot+List/Barclays+identifies+European+consumer+health+winners+and+laggards+as+industry+evolves/26642874.html Sun, 14 Jun 2026 04:00:00 -0400 BDRFY DANOY HLN KMB UL http://www.streetinsider.com/Hot+List/Barclays+identifies+European+consumer+health+winners+and+laggards+as+industry+evolves/26642874.html <p>In recent years, Consumer Health has emerged as a defined category, though it is still a nascent segment within FMCG. A recent Barclays note says the industry could grow to have an estimated market size of $547 billion by 2030E. In the note, firm analysts say the sector is somewhat misunderstood, and identify winners and laggards among European consumer health companies.</p><p>Unilever (LON: ULVR) (NYSE: UL), Haleon (NYSE: HLN) (LON: HLN) and Danone (EPA: BN) (OTC: DANOY) are Barclays’ preferred names in the European Consumer Health space. Barclays’ least preferred names in the space are Beiersdorf (ETR: BEI) (OTC: BDRFY), and http://www.streetinsider.com/Hot+List/Barclays+identifies+European+consumer+health+winners+and+laggards+as+industry+evolves/26642874.html Sun, 14 Jun 2026 04:00:00 -0400 BDRFY DANOY HLN KMB UL http://www.streetinsider.com/Hot+List+Pro/Barclays+identifies+European+consumer+health+winners+and+laggards+as+industry+evolves/26642874.html <p>In recent years, Consumer Health has emerged as a defined category, though it is still a nascent segment within FMCG. A recent Barclays note says the industry could grow to have an estimated market size of $547 billion by 2030E. In the note, firm analysts say the sector is somewhat misunderstood, and identify winners and laggards among European consumer health companies.</p><p>Unilever (LON: ULVR) (NYSE: UL), Haleon (NYSE: HLN) (LON: HLN) and Danone (EPA: BN) (OTC: DANOY) are Barclays’ preferred names in the European Consumer Health space. Barclays’ least preferred names in the space are Beiersdorf (ETR: BEI) (OTC: BDRFY), and http://www.streetinsider.com/Hot+List+Pro/Barclays+identifies+European+consumer+health+winners+and+laggards+as+industry+evolves/26642874.html Sun, 14 Jun 2026 04:00:00 -0400 BDRFY DANOY HLN KMB UL http://www.streetinsider.com/Hot+List+Pro/Barclays+identifies+European+consumer+health+winners+and+laggards+as+industry+evolves/26642874.html <p>In recent years, Consumer Health has emerged as a defined category, though it is still a nascent segment within FMCG. A recent Barclays note says the industry could grow to have an estimated market size of $547 billion by 2030E. In the note, firm analysts say the sector is somewhat misunderstood, and identify winners and laggards among European consumer health companies.</p><p>Unilever (LON: ULVR) (NYSE: UL), Haleon (NYSE: HLN) (LON: HLN) and Danone (EPA: BN) (OTC: DANOY) are Barclays’ preferred names in the European Consumer Health space. Barclays’ least preferred names in the space are Beiersdorf (ETR: BEI) (OTC: BDRFY), and http://www.streetinsider.com/Hot+List+Pro/Barclays+identifies+European+consumer+health+winners+and+laggards+as+industry+evolves/26642874.html Sun, 14 Jun 2026 04:00:00 -0400 BDRFY DANOY HLN KMB UL http://www.streetinsider.com/Hot+List+Pro/Barclays+identifies+European+consumer+health+winners+and+laggards+as+industry+evolves/26642874.html <p>In recent years, Consumer Health has emerged as a defined category, though it is still a nascent segment within FMCG. A recent Barclays note says the industry could grow to have an estimated market size of $547 billion by 2030E. In the note, firm analysts say the sector is somewhat misunderstood, and identify winners and laggards among European consumer health companies.</p><p>Unilever (LON: ULVR) (NYSE: UL), Haleon (NYSE: HLN) (LON: HLN) and Danone (EPA: BN) (OTC: DANOY) are Barclays’ preferred names in the European Consumer Health space. Barclays’ least preferred names in the space are Beiersdorf (ETR: BEI) (OTC: BDRFY), and http://www.streetinsider.com/Hot+List+Pro/Barclays+identifies+European+consumer+health+winners+and+laggards+as+industry+evolves/26642874.html Sun, 14 Jun 2026 04:00:00 -0400 BDRFY DANOY HLN KMB UL http://www.streetinsider.com/Hot+List+Pro/Barclays+identifies+European+consumer+health+winners+and+laggards+as+industry+evolves/26642874.html <p>In recent years, Consumer Health has emerged as a defined category, though it is still a nascent segment within FMCG. A recent Barclays note says the industry could grow to have an estimated market size of $547 billion by 2030E. In the note, firm analysts say the sector is somewhat misunderstood, and identify winners and laggards among European consumer health companies.</p><p>Unilever (LON: ULVR) (NYSE: UL), Haleon (NYSE: HLN) (LON: HLN) and Danone (EPA: BN) (OTC: DANOY) are Barclays’ preferred names in the European Consumer Health space. Barclays’ least preferred names in the space are Beiersdorf (ETR: BEI) (OTC: BDRFY), and http://www.streetinsider.com/Hot+List+Pro/Barclays+identifies+European+consumer+health+winners+and+laggards+as+industry+evolves/26642874.html Sun, 14 Jun 2026 04:00:00 -0400 BDRFY DANOY HLN KMB UL http://www.streetinsider.com/Hot+List+Pro/Barclays+identifies+European+consumer+health+winners+and+laggards+as+industry+evolves/26642874.html <p>In recent years, Consumer Health has emerged as a defined category, though it is still a nascent segment within FMCG. A recent Barclays note says the industry could grow to have an estimated market size of $547 billion by 2030E. In the note, firm analysts say the sector is somewhat misunderstood, and identify winners and laggards among European consumer health companies.</p><p>Unilever (LON: ULVR) (NYSE: UL), Haleon (NYSE: HLN) (LON: HLN) and Danone (EPA: BN) (OTC: DANOY) are Barclays’ preferred names in the European Consumer Health space. Barclays’ least preferred names in the space are Beiersdorf (ETR: BEI) (OTC: BDRFY), and http://www.streetinsider.com/Hot+List+Pro/Barclays+identifies+European+consumer+health+winners+and+laggards+as+industry+evolves/26642874.html Sun, 14 Jun 2026 04:00:00 -0400 BDRFY DANOY HLN KMB UL http://www.streetinsider.com/Press+Releases/Advil+Challenges+Sports+Culture%E2%80%99s+%E2%80%9CNo+Pain+No+Gain%E2%80%9D+Mentality+This+Summer/26620034.html <p class="bwalignc"> <i>The brand is launching Rewriting Pain, a new campaign and partnership with soccer legend Jozy Altidore to redefine what strength looks like</i> </p><p class="bwalignc"> Key Takeaways: </p><ul class="bwlistdisc"> <li> Advil is launching <i>Rewriting Pain</i>, a new campaign challenging sports culture’s “no pain no gain” mentality and redefining strength as confronting pain, not ignoring it. </li> <li> New research commissioned by Advil reveals 87% of current and former everyday athletes agree sports culture treats pain as a necessary part of success. </li> <li> Legendary U.S. Men’s National Team forward and successful investor and entrepreneur, Jozy Altidore is partnering with Advil to encourage people to rethink outdated attitudes around pain, recovery and http://www.streetinsider.com/Press+Releases/Advil+Challenges+Sports+Culture%E2%80%99s+%E2%80%9CNo+Pain+No+Gain%E2%80%9D+Mentality+This+Summer/26620034.html Tue, 09 Jun 2026 07:00:00 -0400 A.50204389 HLN HLN O.00066489 O.52678883 http://www.streetinsider.com/Press+Releases/Advil+Challenges+Sports+Culture%E2%80%99s+%E2%80%9CNo+Pain+No+Gain%E2%80%9D+Mentality+This+Summer/26620034.html <p class="bwalignc"> <i>The brand is launching Rewriting Pain, a new campaign and partnership with soccer legend Jozy Altidore to redefine what strength looks like</i> </p><p class="bwalignc"> Key Takeaways: </p><ul class="bwlistdisc"> <li> Advil is launching <i>Rewriting Pain</i>, a new campaign challenging sports culture’s “no pain no gain” mentality and redefining strength as confronting pain, not ignoring it. </li> <li> New research commissioned by Advil reveals 87% of current and former everyday athletes agree sports culture treats pain as a necessary part of success. </li> <li> Legendary U.S. Men’s National Team forward and successful investor and entrepreneur, Jozy Altidore is partnering with Advil to encourage people to rethink outdated attitudes around pain, recovery and http://www.streetinsider.com/Press+Releases/Advil+Challenges+Sports+Culture%E2%80%99s+%E2%80%9CNo+Pain+No+Gain%E2%80%9D+Mentality+This+Summer/26620034.html Tue, 09 Jun 2026 07:00:00 -0400 A.50204389 HLN HLN O.00066489 O.52678883 http://www.streetinsider.com/Press+Releases/Advil+Challenges+Sports+Culture%E2%80%99s+%E2%80%9CNo+Pain+No+Gain%E2%80%9D+Mentality+This+Summer/26620034.html <p class="bwalignc"> <i>The brand is launching Rewriting Pain, a new campaign and partnership with soccer legend Jozy Altidore to redefine what strength looks like</i> </p><p class="bwalignc"> Key Takeaways: </p><ul class="bwlistdisc"> <li> Advil is launching <i>Rewriting Pain</i>, a new campaign challenging sports culture’s “no pain no gain” mentality and redefining strength as confronting pain, not ignoring it. </li> <li> New research commissioned by Advil reveals 87% of current and former everyday athletes agree sports culture treats pain as a necessary part of success. </li> <li> Legendary U.S. Men’s National Team forward and successful investor and entrepreneur, Jozy Altidore is partnering with Advil to encourage people to rethink outdated attitudes around pain, recovery and http://www.streetinsider.com/Press+Releases/Advil+Challenges+Sports+Culture%E2%80%99s+%E2%80%9CNo+Pain+No+Gain%E2%80%9D+Mentality+This+Summer/26620034.html Tue, 09 Jun 2026 07:00:00 -0400 A.50204389 HLN HLN O.00066489 O.52678883 http://www.streetinsider.com/Press+Releases/Advil+Challenges+Sports+Culture%E2%80%99s+%E2%80%9CNo+Pain+No+Gain%E2%80%9D+Mentality+This+Summer/26620034.html <p class="bwalignc"> <i>The brand is launching Rewriting Pain, a new campaign and partnership with soccer legend Jozy Altidore to redefine what strength looks like</i> </p><p class="bwalignc"> Key Takeaways: </p><ul class="bwlistdisc"> <li> Advil is launching <i>Rewriting Pain</i>, a new campaign challenging sports culture’s “no pain no gain” mentality and redefining strength as confronting pain, not ignoring it. </li> <li> New research commissioned by Advil reveals 87% of current and former everyday athletes agree sports culture treats pain as a necessary part of success. </li> <li> Legendary U.S. Men’s National Team forward and successful investor and entrepreneur, Jozy Altidore is partnering with Advil to encourage people to rethink outdated attitudes around pain, recovery and http://www.streetinsider.com/Press+Releases/Advil+Challenges+Sports+Culture%E2%80%99s+%E2%80%9CNo+Pain+No+Gain%E2%80%9D+Mentality+This+Summer/26620034.html Tue, 09 Jun 2026 07:00:00 -0400 A.50204389 HLN HLN O.00066489 O.52678883 http://www.streetinsider.com/Press+Releases/Advil+Challenges+Sports+Culture%E2%80%99s+%E2%80%9CNo+Pain+No+Gain%E2%80%9D+Mentality+This+Summer/26620034.html <p class="bwalignc"> <i>The brand is launching Rewriting Pain, a new campaign and partnership with soccer legend Jozy Altidore to redefine what strength looks like</i> </p><p class="bwalignc"> Key Takeaways: </p><ul class="bwlistdisc"> <li> Advil is launching <i>Rewriting Pain</i>, a new campaign challenging sports culture’s “no pain no gain” mentality and redefining strength as confronting pain, not ignoring it. </li> <li> New research commissioned by Advil reveals 87% of current and former everyday athletes agree sports culture treats pain as a necessary part of success. </li> <li> Legendary U.S. Men’s National Team forward and successful investor and entrepreneur, Jozy Altidore is partnering with Advil to encourage people to rethink outdated attitudes around pain, recovery and http://www.streetinsider.com/Press+Releases/Advil+Challenges+Sports+Culture%E2%80%99s+%E2%80%9CNo+Pain+No+Gain%E2%80%9D+Mentality+This+Summer/26620034.html Tue, 09 Jun 2026 07:00:00 -0400 A.50204389 HLN HLN O.00066489 O.52678883 http://www.streetinsider.com/Business+Wire/Advil+Challenges+Sports+Culture%E2%80%99s+%E2%80%9CNo+Pain+No+Gain%E2%80%9D+Mentality+This+Summer/26620034.html <p class="bwalignc"> <i>The brand is launching Rewriting Pain, a new campaign and partnership with soccer legend Jozy Altidore to redefine what strength looks like</i> </p><p class="bwalignc"> Key Takeaways: </p><ul class="bwlistdisc"> <li> Advil is launching <i>Rewriting Pain</i>, a new campaign challenging sports culture’s “no pain no gain” mentality and redefining strength as confronting pain, not ignoring it. </li> <li> New research commissioned by Advil reveals 87% of current and former everyday athletes agree sports culture treats pain as a necessary part of success. </li> <li> Legendary U.S. Men’s National Team forward and successful investor and entrepreneur, Jozy Altidore is partnering with Advil to encourage people to rethink outdated attitudes around pain, recovery and http://www.streetinsider.com/Business+Wire/Advil+Challenges+Sports+Culture%E2%80%99s+%E2%80%9CNo+Pain+No+Gain%E2%80%9D+Mentality+This+Summer/26620034.html Tue, 09 Jun 2026 07:00:00 -0400 A.50204389 HLN HLN O.00066489 O.52678883 http://www.streetinsider.com/Business+Wire/Advil+Challenges+Sports+Culture%E2%80%99s+%E2%80%9CNo+Pain+No+Gain%E2%80%9D+Mentality+This+Summer/26620034.html <p class="bwalignc"> <i>The brand is launching Rewriting Pain, a new campaign and partnership with soccer legend Jozy Altidore to redefine what strength looks like</i> </p><p class="bwalignc"> Key Takeaways: </p><ul class="bwlistdisc"> <li> Advil is launching <i>Rewriting Pain</i>, a new campaign challenging sports culture’s “no pain no gain” mentality and redefining strength as confronting pain, not ignoring it. </li> <li> New research commissioned by Advil reveals 87% of current and former everyday athletes agree sports culture treats pain as a necessary part of success. </li> <li> Legendary U.S. Men’s National Team forward and successful investor and entrepreneur, Jozy Altidore is partnering with Advil to encourage people to rethink outdated attitudes around pain, recovery and http://www.streetinsider.com/Business+Wire/Advil+Challenges+Sports+Culture%E2%80%99s+%E2%80%9CNo+Pain+No+Gain%E2%80%9D+Mentality+This+Summer/26620034.html Tue, 09 Jun 2026 07:00:00 -0400 A.50204389 HLN HLN O.00066489 O.52678883 http://www.streetinsider.com/Business+Wire/Advil+Challenges+Sports+Culture%E2%80%99s+%E2%80%9CNo+Pain+No+Gain%E2%80%9D+Mentality+This+Summer/26620034.html <p class="bwalignc"> <i>The brand is launching Rewriting Pain, a new campaign and partnership with soccer legend Jozy Altidore to redefine what strength looks like</i> </p><p class="bwalignc"> Key Takeaways: </p><ul class="bwlistdisc"> <li> Advil is launching <i>Rewriting Pain</i>, a new campaign challenging sports culture’s “no pain no gain” mentality and redefining strength as confronting pain, not ignoring it. </li> <li> New research commissioned by Advil reveals 87% of current and former everyday athletes agree sports culture treats pain as a necessary part of success. </li> <li> Legendary U.S. Men’s National Team forward and successful investor and entrepreneur, Jozy Altidore is partnering with Advil to encourage people to rethink outdated attitudes around pain, recovery and http://www.streetinsider.com/Business+Wire/Advil+Challenges+Sports+Culture%E2%80%99s+%E2%80%9CNo+Pain+No+Gain%E2%80%9D+Mentality+This+Summer/26620034.html Tue, 09 Jun 2026 07:00:00 -0400 A.50204389 HLN HLN O.00066489 O.52678883